Literature DB >> 19463651

The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia.

Hiran C Fernando1, Sudish C Murthy, Wayne Hofstetter, Joseph B Shrager, Charles Bridges, John D Mitchell, Rodney J Landreneau, Ellen R Clough, Thomas J Watson.   

Abstract

The management of Barrett's esophagus with high-grade dysplasia is controversial. The standard of care has traditionally been esophagectomy. However, a number of treatment options aimed at esophageal preservation are increasingly being utilized by many centers. These esophageal-sparing approaches include endoscopic surveillance, mucosal ablation, and endoscopic mucosal resection. In this guideline we review the best evidence supporting these commonly used strategies for high-grade dysplasia to better define management and guide future investigation.

Entities:  

Mesh:

Year:  2009        PMID: 19463651     DOI: 10.1016/j.athoracsur.2009.04.032

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

Review 1.  Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?

Authors:  Vani J A Konda; Mark K Ferguson
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

2.  CAGS and ACS evidence based reviews in surgery. Guidelines for the management of Barrett esophagus with high-grade dysplasia?

Authors:  Harry J Henteleff; James C Ellsmere; Nabil Rizk
Journal:  Can J Surg       Date:  2011-10       Impact factor: 2.089

3.  Low prevalence of invasive adenocarcinoma and occult cancer on esophageal resection for Barrett's esophagus with high-grade dysplasia: Evidence for conservative management.

Authors:  Deepa T Patil; Thomas P Plesec; John R Goldblum
Journal:  J Gastrointest Oncol       Date:  2011-03

Review 4.  Update on staging and surgical treatment options for esophageal cancer.

Authors:  Donald E Low
Journal:  J Gastrointest Surg       Date:  2011-05       Impact factor: 3.452

Review 5.  Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus.

Authors:  Joseph D Feuerstein; Natalia E Castillo; Mona Akbari; Edward Belkin; Jeffrey J Lewandowski; Christine M Hurley; Samuel Lloyd; Daniel A Leffler; Adam S Cheifetz
Journal:  Dig Dis Sci       Date:  2016-06-15       Impact factor: 3.199

6.  Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.

Authors:  Hector R Nava; Shyam S Allamaneni; Thomas J Dougherty; Michele T Cooper; Wei Tan; Gregory Wilding; Barbara W Henderson
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

7.  Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study.

Authors:  James D Luketich; Arjun Pennathur; Yoko Franchetti; Paul J Catalano; Scott Swanson; David J Sugarbaker; Alberto De Hoyos; Michael A Maddaus; Ninh T Nguyen; Al B Benson; Hiran C Fernando
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

Review 8.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

9.  Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.

Authors:  Prashanthi N Thota; Alaa Sada; Madhusudhan R Sanaka; Sunguk Jang; Rocio Lopez; John R Goldblum; Xiuli Liu; John A Dumot; John Vargo; Gregory Zuccarro
Journal:  Surg Endosc       Date:  2016-07-21       Impact factor: 4.584

10.  Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma: a Canadian experience.

Authors:  Denise Tami Yamashita; Chao Li; Drew Bethune; Harry Henteleff; James Ellsmere
Journal:  Can J Surg       Date:  2017-04       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.